The virtual event comprises a series of talks, breakouts and panel discussion on the key considerations for commercialisation and translation of cell and gene therapy research, and how to prepare and ensure commercial success for your advanced therapy projects.
Sessions include: Overcoming barriers to scale-up manufacturing, Addressing current and future pre-clinical ATMP development and regulatory needs and Considering your intellectual property and commercial needs